Neurotech’s Encelto is surgically implanted and delivers genetically modified cell therapy to the eye Neurotech Pharmaceuticals Inc.’s research efforts are paying off. The biotech company, focused on ...
3d
Stockhead on MSNTop of mind: ASX companies tackling neurological disordersSeveral ASX healthcare companies are leading the charge in finding new treatments for complex neurological disorders.
Researchers used a virtual reality game and functional MRI to uncover how children's brains with ADHD respond differently during active tasks.
TORONTO, March 25, 2025 /CNW/ - The Ontario Brain Institute (OBI) is pleased to announce a joint new initiative with EpiSign Inc., paving the way for improved diagnosis and care for people with ...
Neuroplasticity Enhancement Devices Market The growing existence of Alzheimer's and Parkinson's disease globally is driving the market dema ...
Having a chip in your brain that can translate your thoughts into computer commands may sound like science fiction - but it is a reality for Noland Arbaugh. In January 2024 - eight years after he ...
Clinical-stage biopharmaceutical development company focused predominately on paediatric neurological disorders with a broad-spectrum oral cannabinoid drug therapy called NTI164.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results